75 related articles for article (PubMed ID: 22954220)
1. Creative deaminases, self-inflicted damage, and genome evolution.
Conticello SG
Ann N Y Acad Sci; 2012 Sep; 1267():79-85. PubMed ID: 22954220
[TBL] [Abstract][Full Text] [Related]
2. APOBECs and virus restriction.
Harris RS; Dudley JP
Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
[TBL] [Abstract][Full Text] [Related]
3. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast.
Lada AG; Krick CF; Kozmin SG; Mayorov VI; Karpova TS; Rogozin IB; Pavlov YI
Biochemistry (Mosc); 2011 Jan; 76(1):131-46. PubMed ID: 21568845
[TBL] [Abstract][Full Text] [Related]
4. A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.
King JJ; Larijani M
Front Immunol; 2017; 8():351. PubMed ID: 28439266
[TBL] [Abstract][Full Text] [Related]
5. The somatic autosomal mutation matrix in cancer genomes.
Temiz NA; Donohue DE; Bacolla A; Vasquez KM; Cooper DN; Mudunuri U; Ivanic J; Cer RZ; Yi M; Stephens RM; Collins JR; Luke BT
Hum Genet; 2015 Aug; 134(8):851-64. PubMed ID: 26001532
[TBL] [Abstract][Full Text] [Related]
6. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Schulze K; Imbeaud S; Letouzé E; Alexandrov LB; Calderaro J; Rebouissou S; Couchy G; Meiller C; Shinde J; Soysouvanh F; Calatayud AL; Pinyol R; Pelletier L; Balabaud C; Laurent A; Blanc JF; Mazzaferro V; Calvo F; Villanueva A; Nault JC; Bioulac-Sage P; Stratton MR; Llovet JM; Zucman-Rossi J
Nat Genet; 2015 May; 47(5):505-511. PubMed ID: 25822088
[TBL] [Abstract][Full Text] [Related]
8. Lagging-strand replication shapes the mutational landscape of the genome.
Reijns MAM; Kemp H; Ding J; de Procé SM; Jackson AP; Taylor MS
Nature; 2015 Feb; 518(7540):502-506. PubMed ID: 25624100
[TBL] [Abstract][Full Text] [Related]
9. Repair of naturally occurring mismatches can induce mutations in flanking DNA.
Chen J; Miller BF; Furano AV
Elife; 2014 Apr; 3():e02001. PubMed ID: 24843013
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3B mutagenesis in cancer.
Kuong KJ; Loeb LA
Nat Genet; 2013 Sep; 45(9):964-5. PubMed ID: 23985681
[TBL] [Abstract][Full Text] [Related]
11. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
[TBL] [Abstract][Full Text] [Related]
12. AID and Apobec3G haphazard deamination and mutational diversity.
Jaszczur M; Bertram JG; Pham P; Scharff MD; Goodman MF
Cell Mol Life Sci; 2013 Sep; 70(17):3089-108. PubMed ID: 23178850
[TBL] [Abstract][Full Text] [Related]
13. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
14. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.
Kockler ZW; Gordenin DA
Cells; 2021 Jun; 10(6):. PubMed ID: 34202997
[TBL] [Abstract][Full Text] [Related]
15. APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.
Soleymanjahi S; Blanc V; Davidson N
RNA; 2021 Jun; 27(8):876-90. PubMed ID: 34083494
[TBL] [Abstract][Full Text] [Related]
16. A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results.
Sessa M; Cavazzini F; Cavallari M; Rigolin GM; Cuneo A
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33287156
[TBL] [Abstract][Full Text] [Related]
17. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
Green AM; Weitzman MD
DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
[TBL] [Abstract][Full Text] [Related]
19. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
20. The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.
Chen Q; Xiao X; Wolfe A; Chen XS
J Mol Biol; 2016 Jul; 428(13):2661-70. PubMed ID: 27063502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
